12
Participants
Start Date
June 30, 2012
Primary Completion Date
February 28, 2015
Study Completion Date
February 28, 2015
nabilone 0.5 mg
nabilone 0.5 mg tablets od titrated to a maximum daily dose of 3mg po over an 11-week phase
placebo
placebo 0.5 mg po daily, dose titrated to a maximum daily dose of 3.0mg po over an 11-week phase
Health Sciences Centre Rehabilitation Hospital, Winnipeg
The Manitoba Spinal Cord Injury Research Fund
UNKNOWN
Canadian Paraplegic Association
OTHER
Health Sciences Centre Foundation, Manitoba
OTHER
University of Manitoba
OTHER